Early changes of fecal short‐chain fatty acid levels in patients with mild cognitive impairments

AIMS: To compare the fecal levels of short‐chain fatty acids (SCFAs) in patients with mild cognitive impairment (MCI) and normal controls (NCs) and to examine whether fecal SCFAs could be used as the biomarker for the identification of patients with MCI. To examine the relationship between fecal SCF...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Chao, Li, Binyin, He, Yixi, Huang, Pai, Du, Juanjuan, He, Guiying, Zhang, Pingchen, Tang, Huidong, Chen, Shengdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580335/
https://www.ncbi.nlm.nih.gov/pubmed/37144597
http://dx.doi.org/10.1111/cns.14252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580335/
https://www.ncbi.nlm.nih.gov/pubmed/37144597
http://dx.doi.org/10.1111/cns.14252

Ejemplares similares